Oral micronutrient supplementation showed no benefit on geographic atrophy lesion growth among a patient group from the OAKS and DERBY trials, according to a speaker ...

Multimodal imaging, including OCT and FAF, is crucial for differentiating between AMD and IRDs, enabling precise diagnosis.

The biotech’s lead asset, AVD-104, failed to beat Astellas’ Izervay at slowing the rate of retina lesion growth, the primary ...

Aviceda Therapeutics has released topline results from its phase 2b study, SIGLEC, evaluating AVD-104 in patients with ...

SIGLEC Phase 2b data support AVD-104 as a potential therapy to reduce GA lesion growth, preserve and improve visual acuity, and reduce conversion to neovascular AMD across all GA lesion types at 1 ...

Vision scientist Michael Webster, PhD, at the University of Nevada, has shown that the environment influences color perception. He has studied how people in tropical environments might calibrate their ...

K8 is a member of a new class of inflammasome-inhibiting drugs called kamuvudines. Inflammasome Therapeutics has completed enrollment in a multicenter, dose-ranging phase 2 trial (NCT06164587) for its ...

(NAPSI)—For the nearly 40 million Americans living with diabetes, the threat to their vision unfolds quietly, often without ...

A former Georgia beauty queen killed her boyfriend’s toddler son in a jealous fit of rage because she wanted to start a family with her partner and have their own child, prosecutors alleged. Trinity ...

The retina is a layered structure that lines the inner surface of the eye. It consists of layers of neurons: light-sensitive photoreceptor cells, bipolar cells, horizontal cells, amacrine cells and ...

It was once believed that mice had relatively poor vision. Turns out mice are far from blind – and studying how their vision ...

Who bought what and why this year? Here’s a (mostly) comprehensive list of all the notable ad tech, agency and digital ...